Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 6.51% | |
| Drug Manufacturers - General | 33.16% | 9.37% | |
| Healthcare Plans | 13.55% | 0.61% | |
| Medical Devices | 12.71% | 6.53% | |
| Biotechnology | 11.31% | -1.80% | |
| Diagnostics & Research | 10.80% | 0.67% | |
| Medical Instruments & Supplies | 7.81% | 25.60% | |
| Medical Care Facilities | 2.94% | 15.54% | |
| Drug Manufacturers - Specialty & Generic | 2.81% | -0.21% | |
| Medical Distribution | 2.52% | 19.87% | |
| Health Information Services | 2.27% | 19.07% | |
| Pharmaceutical Retailers | 0.12% | -64.12% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 813.33 | 999.43 | 11.02% | | | | Buy | |
| 605.23 | 625.10 | 8.39% | | | | Buy | |
| 152.36 | 175.98 | 5.53% | | | | Buy | |
| 181.50 | 208.90 | 4.83% | | | | Buy | |
| 101.85 | 133.43 | 3.88% | | | | Buy | |
| 534.42 | 657.43 | 3.08% | | | | Buy | |
| 116.29 | 130.24 | 3.04% | | | | Buy | |
| 541.71 | 539.24 | 2.91% | | | | Buy | |
| 240.87 | 288.34 | 2.62% | | | | Buy | |
| 278.32 | 335.10 | 2.25% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 146.82 | 39.816B | 0.09% | | |
| 270.65 | 20.549B | 0.10% | | |
| 97.69 | 7.244B | 0.35% | | |
| 140.00 | 7.086B | 0.45% | | |
| 60.70 | 4.783B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 214.44 | 45.697B | 0.30% | | |
| 90.45 | 45.697B | 0.30% | | |
| 135.45 | 20.549B | 0.10% | | |
| 96.64 | 14.589B | 0.80% | | |
| 96.28 | 14.589B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Bristol-Myers Squibb Co.
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its merger with Celgene in November 2019. The BMY shares are a component of the S&P 500.
RatingPrice TargetMarket Update: BMY, CMG
The major indices are mixed at midday, but movement is marginal. The Job Openings report showed healthy gains in new job listings last month. The yield on the 10-year Treasury note is around 4.21%. Oil has popped up 2.8% and is over $70 per barrel. Bitcoin is down 1% at $95,209.
Daily – Vickers Top Buyers & Sellers for 12/03/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Insider Picks for 12/03/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
